Effects of dexmedetomidine on preventing sleep disturbance and delirium during high flow oxygen therapy in patients with acute respiratory failure.
Not Applicable
- Conditions
- Adult patients with acute respiratory failure treated with high flow oxygen therapy
- Registration Number
- JPRN-UMIN000015650
- Lead Sponsor
- Tokushima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
Major cardiovascular disease, shock, cerebrovascular disease, known sleep apnea syndrome, mental disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep quality and quantity (total sleep time, the rate of each sleep stage: non-REM sleep stage 1-3, REM sleep) and the incidence rate of delirium.
- Secondary Outcome Measures
Name Time Method successful rate of liberation from high flow oxygen therapy, the length of ICU stay, and mortality.